Unilever


Beauty & Well-Being and PC drive the company's growth

11/03/25 -"We have revised our model to incorporate the inline FY24 sales of EUR 60.8bn (-0.2% vs. expectations), leading to a slight downward adjustment in our FY25E and FY26E sales estimates. The key drivers ..."

Pages
53
Language
English
Published on
11/03/25
You may also be interested by these reports :
06/05/25
We have applied discounts to P/E, EV/EBITDA, and P/Book to reflect the lack of diversification, the smaller size and scale of the group’s businesses ...

30/04/25
Haleon’s Q1 organic sales largely aligned with market expectations, showing growth across all segments. Management reaffirmed its 2025 targets. ...

29/04/25
Puig reported an encouraging start to the year, outperforming the global beauty market. The ongoing softness in the premium makeup segment was fully ...

29/04/25
Essity (Add; Sweden), an attractive Health and Hygiene play, has further sharpened its ‘Health’ focus in recent years, resulting in reduced ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO